Metformin and ageing: improving ageing outcomes beyond glycaemic control
Open Access
- 2 August 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 60 (9), 1630-1638
- https://doi.org/10.1007/s00125-017-4349-5
Abstract
In a world where the population is ageing, there is growing interest and demand for research evaluating strategies that address the ageing process. After 60 years of successful use of metformin in our pharmaceutical armamentarium, we are learning that, beyond improving glycaemic control, metformin may have additional mechanisms and pathways of action that need further study. Although, metformin’s effect on clinical ageing outcomes may still be considered speculative, the findings from studies into cellular and animal models and from observational and pilot human studies support the existence of beneficial effects on ageing. At present, progress for human research, using randomised clinical trials to evaluate metformin’s clinical impact, has just started. Here, we present a review on the ageing process and the mechanisms involved, and the role that metformin may have to counter these. We go on to discuss the upcoming large randomised clinical trials that may provide insight on the use of metformin for ageing outcomes beyond glycaemic control.This publication has 66 references indexed in Scilit:
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine MetabolismCell, 2013
- Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering PhenomenonCardiovascular Drugs and Therapy, 2012
- Targeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention ProgramArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- The Critical Role of Metabolic Pathways in AgingDiabetes, 2012
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA DamageCancer Prevention Research, 2012
- Frailty Transitions in the San Antonio Longitudinal Study of AgingJournal of the American Geriatrics Society, 2012
- Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidityNeuroscience & Biobehavioral Reviews, 2012
- Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugsDiabetes, Obesity and Metabolism, 2012
- Metformin slows down aging and extends life span of female SHR miceCell Cycle, 2008
- Geriatric Syndromes: Clinical, Research, and Policy Implications of a Core Geriatric ConceptJournal of the American Geriatrics Society, 2007